Dr. Martens plc (OTCPK:DRMTY) Q2 2026 Earnings Call November 20, 2025 4:30 AM EST Company Participants Ije Nwokorie Giles Wilson - CFO & Director Conference Call Participants John Stevenson - Peel Hunt LLP, Research Division Anne Critchlow - Joh. Berenberg, Gossler & Co. KG, Research Division Kate Calvert - Investec Bank plc, Research Division Alison Lygo - Deutsche Bank AG, Research Division Presentation Ije Nwokorie Like I said, we've been busy, and I'm proud of what our people have been up to in the first half of the year.
| Textiles, Apparel & Luxury Goods Industry | Consumer Discretionary Sector | Ije Nwokorie CEO | OTC PINK Exchange | 26140G100 CUSIP |
| GB Country | 2,377 Employees | 28 Aug 2026 Last Dividend | - Last Split | - IPO Date |
Dr. Martens plc is a distinguished company renowned for its iconic footwear, rooted in the tradition of quality and innovation since its establishment in 1945. Based in London, United Kingdom, the company has grown to become a global entity, serving diverse markets across Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It focuses on the design, development, procurement, marketing, sale, and distribution of its products, all under the internationally recognized Dr. Martens brand name. The brand has embedded itself in the fabric of various cultures and movements throughout its history, transcending its original workwear roots to become a symbol of self-expression and rebellion among various subcultures around the world.